nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—CARTPT—nerve—chronic kidney failure	0.0416	0.161	CbGeAlD
Amphetamine—CARTPT—blood plasma—chronic kidney failure	0.0315	0.122	CbGeAlD
Amphetamine—SLC6A2—sympathetic nervous system—chronic kidney failure	0.0228	0.0886	CbGeAlD
Amphetamine—CARTPT—blood—chronic kidney failure	0.0115	0.0447	CbGeAlD
Amphetamine—SLC6A3—nerve—chronic kidney failure	0.0107	0.0415	CbGeAlD
Amphetamine—SLC18A2—blood plasma—chronic kidney failure	0.0107	0.0415	CbGeAlD
Amphetamine—MAOB—nerve—chronic kidney failure	0.00932	0.0362	CbGeAlD
Amphetamine—SLC6A2—nerve—chronic kidney failure	0.00863	0.0335	CbGeAlD
Amphetamine—DRD2—nerve—chronic kidney failure	0.00786	0.0305	CbGeAlD
Amphetamine—SLC6A4—blood plasma—chronic kidney failure	0.00741	0.0288	CbGeAlD
Amphetamine—MAOB—blood plasma—chronic kidney failure	0.00705	0.0273	CbGeAlD
Amphetamine—CYP2D6—urine—chronic kidney failure	0.00684	0.0266	CbGeAlD
Amphetamine—Phenformin—SLC22A2—chronic kidney failure	0.00502	0.213	CrCbGaD
Amphetamine—SLC18A2—digestive system—chronic kidney failure	0.00411	0.016	CbGeAlD
Amphetamine—SLC18A2—blood—chronic kidney failure	0.00392	0.0152	CbGeAlD
Amphetamine—MAOB—nephron tubule—chronic kidney failure	0.00363	0.0141	CbGeAlD
Amphetamine—CYP2D6—blood plasma—chronic kidney failure	0.00357	0.0139	CbGeAlD
Amphetamine—SLC22A3—renal system—chronic kidney failure	0.00357	0.0139	CbGeAlD
Amphetamine—SLC22A3—urethra—chronic kidney failure	0.00351	0.0136	CbGeAlD
Amphetamine—SLC22A3—kidney—chronic kidney failure	0.00345	0.0134	CbGeAlD
Amphetamine—MAOB—renal system—chronic kidney failure	0.0033	0.0128	CbGeAlD
Amphetamine—MAOB—cardiovascular system—chronic kidney failure	0.00326	0.0127	CbGeAlD
Amphetamine—MAOB—urethra—chronic kidney failure	0.00324	0.0126	CbGeAlD
Amphetamine—SLC22A3—gonad—chronic kidney failure	0.0032	0.0124	CbGeAlD
Amphetamine—MAOB—kidney—chronic kidney failure	0.00319	0.0124	CbGeAlD
Amphetamine—MAOB—cortex of kidney—chronic kidney failure	0.00311	0.0121	CbGeAlD
Amphetamine—SLC22A5—nephron tubule—chronic kidney failure	0.00286	0.0111	CbGeAlD
Amphetamine—SLC6A4—digestive system—chronic kidney failure	0.00285	0.0111	CbGeAlD
Amphetamine—SLC6A2—gonad—chronic kidney failure	0.00274	0.0106	CbGeAlD
Amphetamine—SLC6A4—blood—chronic kidney failure	0.00271	0.0105	CbGeAlD
Amphetamine—MAOB—digestive system—chronic kidney failure	0.00271	0.0105	CbGeAlD
Amphetamine—SLC22A5—renal system—chronic kidney failure	0.0026	0.0101	CbGeAlD
Amphetamine—MAOB—blood—chronic kidney failure	0.00258	0.01	CbGeAlD
Amphetamine—SLC22A5—urethra—chronic kidney failure	0.00255	0.0099	CbGeAlD
Amphetamine—SLC22A5—kidney—chronic kidney failure	0.00251	0.00974	CbGeAlD
Amphetamine—SLC22A5—cortex of kidney—chronic kidney failure	0.00244	0.00949	CbGeAlD
Amphetamine—SLC22A5—digestive system—chronic kidney failure	0.00213	0.00826	CbGeAlD
Amphetamine—SLC22A5—blood—chronic kidney failure	0.00203	0.00787	CbGeAlD
Amphetamine—Phenylpropanolamine—DRD1—chronic kidney failure	0.00189	0.0801	CrCbGaD
Amphetamine—Benzyl alcohol—CYP2B6—chronic kidney failure	0.00181	0.0766	CrCbGaD
Amphetamine—Selegiline—CYP2B6—chronic kidney failure	0.00174	0.0735	CrCbGaD
Amphetamine—CYP2D6—renal system—chronic kidney failure	0.00167	0.0065	CbGeAlD
Amphetamine—CYP2D6—kidney—chronic kidney failure	0.00162	0.00628	CbGeAlD
Amphetamine—Pseudoephedrine—TNF—chronic kidney failure	0.00141	0.0596	CrCbGaD
Amphetamine—CYP2D6—digestive system—chronic kidney failure	0.00137	0.00533	CbGeAlD
Amphetamine—Tranylcypromine—CYP2C19—chronic kidney failure	0.00135	0.0573	CrCbGaD
Amphetamine—Benzphetamine—CYP2B6—chronic kidney failure	0.00133	0.0561	CrCbGaD
Amphetamine—CYP2D6—blood—chronic kidney failure	0.00131	0.00508	CbGeAlD
Amphetamine—Benzyl alcohol—CYP1A1—chronic kidney failure	0.00109	0.0461	CrCbGaD
Amphetamine—Selegiline—CYP2C19—chronic kidney failure	0.00105	0.0444	CrCbGaD
Amphetamine—Nateglinide—PTGS1—chronic kidney failure	0.00102	0.0432	CrCbGaD
Amphetamine—Phenelzine—CYP2C19—chronic kidney failure	0.000924	0.0391	CrCbGaD
Amphetamine—Tranylcypromine—CYP3A4—chronic kidney failure	0.00086	0.0364	CrCbGaD
Amphetamine—Benzyl alcohol—CYP3A4—chronic kidney failure	0.000695	0.0294	CrCbGaD
Amphetamine—Selegiline—CYP3A4—chronic kidney failure	0.000667	0.0282	CrCbGaD
Amphetamine—Nateglinide—CYP3A4—chronic kidney failure	0.000596	0.0252	CrCbGaD
Amphetamine—Phenelzine—CYP3A4—chronic kidney failure	0.000587	0.0249	CrCbGaD
Amphetamine—Selegiline—ABCB1—chronic kidney failure	0.000555	0.0235	CrCbGaD
Amphetamine—Nateglinide—ALB—chronic kidney failure	0.00052	0.022	CrCbGaD
Amphetamine—Benzphetamine—CYP3A4—chronic kidney failure	0.000509	0.0216	CrCbGaD
Amphetamine—TAAR1—Signaling Pathways—AVP—chronic kidney failure	0.000184	0.000257	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic kidney failure	0.000184	0.000256	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SREBF2—chronic kidney failure	0.000183	0.000255	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.000177	0.000247	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCC3—chronic kidney failure	0.000177	0.000246	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GCKR—chronic kidney failure	0.000177	0.000246	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000176	0.000245	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EDN1—chronic kidney failure	0.000175	0.000244	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL5—chronic kidney failure	0.000174	0.000242	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LPIN1—chronic kidney failure	0.000173	0.000241	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CPT1A—chronic kidney failure	0.00017	0.000237	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LPL—chronic kidney failure	0.00017	0.000237	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ACAT1—chronic kidney failure	0.00017	0.000237	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2C18—chronic kidney failure	0.00017	0.000236	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LRP2—chronic kidney failure	0.00017	0.000236	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LIPC—chronic kidney failure	0.000166	0.000231	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP2C19—chronic kidney failure	0.000166	0.000231	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—chronic kidney failure	0.000164	0.000228	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic kidney failure	0.000163	0.000227	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000162	0.000225	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000161	0.000224	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NGF—chronic kidney failure	0.000161	0.000224	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SERPINE1—chronic kidney failure	0.000161	0.000224	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000158	0.00022	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MLXIPL—chronic kidney failure	0.000158	0.00022	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCR5—chronic kidney failure	0.000157	0.000218	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—CYP1A1—chronic kidney failure	0.000156	0.000218	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—chronic kidney failure	0.000156	0.000217	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AVP—chronic kidney failure	0.000154	0.000215	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic kidney failure	0.000154	0.000215	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic kidney failure	0.000154	0.000214	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SCARB1—chronic kidney failure	0.000153	0.000214	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000153	0.000212	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS1—chronic kidney failure	0.000152	0.000211	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	0.00015	0.000208	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SREBF1—chronic kidney failure	0.000149	0.000207	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—HMGCR—chronic kidney failure	0.000145	0.000202	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC22A2—chronic kidney failure	0.000145	0.000201	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CPT1A—chronic kidney failure	0.000144	0.000201	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AVP—chronic kidney failure	0.000142	0.000197	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—FASN—chronic kidney failure	0.000142	0.000197	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LIPC—chronic kidney failure	0.000141	0.000196	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP2C19—chronic kidney failure	0.000141	0.000196	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTH—chronic kidney failure	0.00014	0.000194	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.000139	0.000193	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CRHR1—chronic kidney failure	0.000139	0.000193	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AVP—chronic kidney failure	0.000137	0.00019	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—chronic kidney failure	0.000137	0.00019	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.000136	0.000189	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—EDN1—chronic kidney failure	0.000135	0.000188	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—F2—chronic kidney failure	0.000135	0.000187	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCG1—chronic kidney failure	0.000134	0.000187	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL5—chronic kidney failure	0.000134	0.000186	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	0.000132	0.000184	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIP5K1B—chronic kidney failure	0.000132	0.000183	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP3A4—chronic kidney failure	0.000131	0.000183	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SCARB1—chronic kidney failure	0.00013	0.000181	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCA1—chronic kidney failure	0.000129	0.00018	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ARG2—chronic kidney failure	0.000129	0.000179	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS1—chronic kidney failure	0.000129	0.000179	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IRS1—chronic kidney failure	0.000127	0.000177	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTH—chronic kidney failure	0.000127	0.000176	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LCAT—chronic kidney failure	0.000126	0.000176	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SREBF1—chronic kidney failure	0.000126	0.000175	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000126	0.000175	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—chronic kidney failure	0.000125	0.000174	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.000124	0.000172	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—HMGCR—chronic kidney failure	0.000123	0.000171	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—chronic kidney failure	0.000123	0.000171	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—NPY—chronic kidney failure	0.000121	0.000169	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.000121	0.000169	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCR5—chronic kidney failure	0.000121	0.000168	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.00012	0.000167	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—FASN—chronic kidney failure	0.00012	0.000167	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL2—chronic kidney failure	0.00012	0.000167	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.00012	0.000167	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF1—chronic kidney failure	0.000118	0.000164	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CRH—chronic kidney failure	0.000117	0.000163	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OXT—chronic kidney failure	0.000117	0.000163	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—chronic kidney failure	0.000117	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—COL4A5—chronic kidney failure	0.000116	0.000162	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DDC—chronic kidney failure	0.000116	0.000161	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRKD1—chronic kidney failure	0.000113	0.000157	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2B6—chronic kidney failure	0.000113	0.000157	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRKAG2—chronic kidney failure	0.000113	0.000157	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SERPINE1—chronic kidney failure	0.000112	0.000156	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000112	0.000155	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP3A4—chronic kidney failure	0.000111	0.000155	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—NPS—chronic kidney failure	0.000111	0.000154	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—chronic kidney failure	0.000111	0.000154	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPY—chronic kidney failure	0.00011	0.000153	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FABP1—chronic kidney failure	0.00011	0.000153	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAT—chronic kidney failure	0.000109	0.000152	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCA1—chronic kidney failure	0.000109	0.000152	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD1—chronic kidney failure	0.000109	0.000151	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TFDP2—chronic kidney failure	0.000108	0.00015	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOS3—chronic kidney failure	0.000107	0.000149	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCB1—chronic kidney failure	0.000106	0.000148	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CRH—chronic kidney failure	0.000106	0.000148	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OXT—chronic kidney failure	0.000106	0.000148	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000106	0.000147	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SREBF2—chronic kidney failure	0.000105	0.000147	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGXT—chronic kidney failure	0.000104	0.000145	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GATM—chronic kidney failure	0.000104	0.000145	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—F2—chronic kidney failure	0.000104	0.000144	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCC3—chronic kidney failure	0.000102	0.000142	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCKR—chronic kidney failure	0.000102	0.000142	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LPL—chronic kidney failure	0.000101	0.000141	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPS—chronic kidney failure	0.000101	0.00014	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RELA—chronic kidney failure	0.000101	0.00014	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPIN1—chronic kidney failure	9.97e-05	0.000139	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD1—chronic kidney failure	9.88e-05	0.000137	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP1A1—chronic kidney failure	9.79e-05	0.000136	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LRP2—chronic kidney failure	9.77e-05	0.000136	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2C18—chronic kidney failure	9.77e-05	0.000136	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PGF—chronic kidney failure	9.63e-05	0.000134	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACAT1—chronic kidney failure	9.54e-05	0.000133	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—chronic kidney failure	9.43e-05	0.000131	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic kidney failure	9.35e-05	0.00013	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAT—chronic kidney failure	9.25e-05	0.000129	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL2—chronic kidney failure	9.23e-05	0.000128	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—chronic kidney failure	9.13e-05	0.000127	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKAG2—chronic kidney failure	9.05e-05	0.000126	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—chronic kidney failure	9.02e-05	0.000125	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCB1—chronic kidney failure	9e-05	0.000125	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARA—chronic kidney failure	8.95e-05	0.000125	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MLXIPL—chronic kidney failure	8.87e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—COL4A3—chronic kidney failure	8.58e-05	0.000119	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LPL—chronic kidney failure	8.58e-05	0.000119	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NFKB1—chronic kidney failure	8.49e-05	0.000118	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HBEGF—chronic kidney failure	8.4e-05	0.000117	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CPT1A—chronic kidney failure	8.3e-05	0.000116	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic kidney failure	8.29e-05	0.000115	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP1A1—chronic kidney failure	8.28e-05	0.000115	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRHR1—chronic kidney failure	8.19e-05	0.000114	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC22A2—chronic kidney failure	8.11e-05	0.000113	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LIPC—chronic kidney failure	8.09e-05	0.000113	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2C19—chronic kidney failure	8.09e-05	0.000113	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AVP—chronic kidney failure	8.02e-05	0.000112	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LRP2—chronic kidney failure	7.85e-05	0.000109	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—chronic kidney failure	7.72e-05	0.000107	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—chronic kidney failure	7.7e-05	0.000107	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—chronic kidney failure	7.67e-05	0.000107	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—EDN1—chronic kidney failure	7.63e-05	0.000106	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARA—chronic kidney failure	7.58e-05	0.000105	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—chronic kidney failure	7.57e-05	0.000105	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG1—chronic kidney failure	7.54e-05	0.000105	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTH—chronic kidney failure	7.49e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SCARB1—chronic kidney failure	7.48e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS1—chronic kidney failure	7.4e-05	0.000103	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIP5K1B—chronic kidney failure	7.38e-05	0.000103	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—chronic kidney failure	7.3e-05	0.000102	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBB—chronic kidney failure	7.3e-05	0.000102	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AVP—chronic kidney failure	7.28e-05	0.000101	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SREBF1—chronic kidney failure	7.26e-05	0.000101	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ARG2—chronic kidney failure	7.23e-05	0.000101	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LCAT—chronic kidney failure	7.09e-05	9.86e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—chronic kidney failure	7.07e-05	9.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMGCR—chronic kidney failure	7.06e-05	9.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EDN1—chronic kidney failure	6.93e-05	9.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGF23—chronic kidney failure	6.91e-05	9.62e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FASN—chronic kidney failure	6.91e-05	9.61e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—chronic kidney failure	6.87e-05	9.56e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCR5—chronic kidney failure	6.82e-05	9.49e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—chronic kidney failure	6.66e-05	9.26e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—chronic kidney failure	6.55e-05	9.11e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DDC—chronic kidney failure	6.51e-05	9.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPY—chronic kidney failure	6.51e-05	9.05e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP3A4—chronic kidney failure	6.4e-05	8.91e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—chronic kidney failure	6.37e-05	8.86e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	6.32e-05	8.79e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	6.32e-05	8.79e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRKD1—chronic kidney failure	6.32e-05	8.79e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCA1—chronic kidney failure	6.29e-05	8.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OXT—chronic kidney failure	6.28e-05	8.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRH—chronic kidney failure	6.28e-05	8.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCR5—chronic kidney failure	6.19e-05	8.61e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—chronic kidney failure	6.18e-05	8.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NCF1—chronic kidney failure	6.01e-05	8.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPS—chronic kidney failure	5.95e-05	8.28e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF2—chronic kidney failure	5.91e-05	8.23e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—chronic kidney failure	5.85e-05	8.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD1—chronic kidney failure	5.83e-05	8.12e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—chronic kidney failure	5.82e-05	8.1e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCC3—chronic kidney failure	5.71e-05	7.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCKR—chronic kidney failure	5.71e-05	7.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CYBA—chronic kidney failure	5.65e-05	7.86e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—chronic kidney failure	5.63e-05	7.83e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPIN1—chronic kidney failure	5.59e-05	7.78e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LRP2—chronic kidney failure	5.48e-05	7.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	5.48e-05	7.62e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—chronic kidney failure	5.39e-05	7.49e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—chronic kidney failure	5.33e-05	7.41e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—chronic kidney failure	5.33e-05	7.41e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—chronic kidney failure	5.33e-05	7.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—chronic kidney failure	5.31e-05	7.39e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB1—chronic kidney failure	5.18e-05	7.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HBEGF—chronic kidney failure	4.96e-05	6.9e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—chronic kidney failure	4.94e-05	6.87e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—chronic kidney failure	4.93e-05	6.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—chronic kidney failure	4.84e-05	6.73e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP1A1—chronic kidney failure	4.77e-05	6.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—chronic kidney failure	4.73e-05	6.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1A—chronic kidney failure	4.66e-05	6.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LIPC—chronic kidney failure	4.54e-05	6.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	4.54e-05	6.31e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—chronic kidney failure	4.45e-05	6.19e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARA—chronic kidney failure	4.36e-05	6.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVP—chronic kidney failure	4.3e-05	5.98e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SCARB1—chronic kidney failure	4.19e-05	5.83e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS1—chronic kidney failure	4.15e-05	5.77e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EDN1—chronic kidney failure	4.09e-05	5.69e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF1—chronic kidney failure	4.07e-05	5.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—chronic kidney failure	4.06e-05	5.65e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—chronic kidney failure	3.97e-05	5.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMGCR—chronic kidney failure	3.96e-05	5.51e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FASN—chronic kidney failure	3.87e-05	5.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NGF—chronic kidney failure	3.76e-05	5.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCR5—chronic kidney failure	3.66e-05	5.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	3.59e-05	4.99e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—chronic kidney failure	3.56e-05	4.95e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCA1—chronic kidney failure	3.53e-05	4.91e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—chronic kidney failure	3.24e-05	4.51e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—chronic kidney failure	3.14e-05	4.37e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—chronic kidney failure	3.1e-05	4.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—chronic kidney failure	2.99e-05	4.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS1—chronic kidney failure	2.97e-05	4.13e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB1—chronic kidney failure	2.91e-05	4.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—chronic kidney failure	2.86e-05	3.98e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—chronic kidney failure	2.84e-05	3.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—chronic kidney failure	2.8e-05	3.89e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—chronic kidney failure	2.77e-05	3.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—chronic kidney failure	2.75e-05	3.83e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	2.67e-05	3.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—chronic kidney failure	2.61e-05	3.63e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—chronic kidney failure	2.58e-05	3.6e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—chronic kidney failure	2.49e-05	3.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—chronic kidney failure	2.49e-05	3.47e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARA—chronic kidney failure	2.45e-05	3.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RELA—chronic kidney failure	2.35e-05	3.26e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—chronic kidney failure	2.1e-05	2.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—chronic kidney failure	1.99e-05	2.77e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKB1—chronic kidney failure	1.98e-05	2.75e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—chronic kidney failure	1.82e-05	2.53e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—chronic kidney failure	1.8e-05	2.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—chronic kidney failure	1.74e-05	2.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—chronic kidney failure	1.65e-05	2.29e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—chronic kidney failure	1.59e-05	2.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—chronic kidney failure	1.53e-05	2.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—chronic kidney failure	1.24e-05	1.73e-05	CbGpPWpGaD
